Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M97.3Revenue $M31.9Net Margin (%)-95.4Z-Score-6.6
Enterprise Value $M75.8EPS $-1.1Operating Margin %-96.0F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-96.6Higher ROA y-yN
Price/Book3.810-y EBITDA Growth Rate %0Quick Ratio2.4Cash flow > EarningsY
Price/Sales3.15-y EBITDA Growth Rate %0Current Ratio2.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-53.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-79.7Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M39.6ROI % (ttm)-52.7Gross Margin Increase y-yY

Gurus Latest Trades with CDXS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CDXSGeorge Soros 2011-12-31 Sold Out -0.0012%$4.24 - $6.02
($2.63)
$ 2.5-5%Sold Out0
CDXSGeorge Soros 2011-09-30 Buy $4.39 - $10.24
($6.98)
$ 2.5-64%New holding, 14800 sh.14,800
CDXSGeorge Soros 2010-09-30 Sold Out -0.04%$7.11 - $9.77
($8.46)
$ 2.5-70%Sold Out0
CDXSGeorge Soros 2010-06-30 Buy 0.04%$8.69 - $14.45
($11.75)
$ 2.5-79%New holding, 153639 sh.153,639
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CDXS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


CDXS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Yang Patrick YDirector 2014-11-18Buy20,000$2.356.38view
Yang Patrick YDirector 2014-11-17Buy20,000$2.346.84view
CMEA VENTURES LIFE SCIENCES 20Director, 10% Owner 2014-11-10Sell2,921,225$2.375.49view
Yang Patrick YDirector 2014-08-12Buy60,000$2.2212.61view
Yang Patrick YDirector 2014-02-22Sell0$012.61view
Lalonde JamesSVP, R&D 2014-02-05Sell0$012.61view
NICOLS JOHN JPresident & CEO 2013-03-08Buy27,000$2.423.31view
NICOLS JOHN JPresident & CEO 2013-03-07Buy54,000$2.2212.61view
O'Toole David DSVP & CFO 2013-03-04Buy10,000$2.0223.76view
Seufer-Wasserthal PeterSVP, Pharmaceuticals 2013-01-24Sell0$023.76view

Press Releases about CDXS :

    Quarterly/Annual Reports about CDXS:

    News about CDXS:

    Articles On GuruFocus.com
    Weekly 3-Year Lows Highlight: SEAS, AMTG, AHH, NCTY, CDXS Dec 30 2013 
    comment on CDXS Mar 23 2013 
    Weekly CEO Buys Highlight: AKAM, DRC, MDRX, MTG, CDXS Mar 17 2013 
    A New Beginning for Codexis? Mar 08 2013 
    Weekly CFO Buys Highlight: ASNB, FXCM, CDXS, VTNC, BRS Sep 24 2012 

    More From Other Websites
    Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme... Dec 03 2014
    Codexis Uses Its CodeEvolver(R) Protein Engineering Platform Technology to Develop an Enzyme... Dec 03 2014
    Codexis to Present at the LD Micro Main Event VII Conference on December 4 Nov 25 2014
    Codexis to Present at the LD Micro Main Event VII Conference on December 4 Nov 25 2014
    Insider Trading Alert - ITG, CDXS And ARQL Traded By Insiders Nov 21 2014
    CODEXIS INC Financials Nov 15 2014
    10-Q for Codexis, Inc. Nov 08 2014
    CODEXIS INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 07 2014
    CODEXIS INC Files SEC form 10-Q, Quarterly Report Nov 06 2014
    Codexis Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014 Nov 04 2014
    CODEXIS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 04 2014
    Codexis Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2014 Nov 04 2014
    Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors Nov 03 2014
    CODEXIS INC Files SEC form 8-K, Change in Directors or Principal Officers Nov 03 2014
    Codexis Appoints Pam P. Cheng, Merck Global Executive, to Board of Directors Nov 03 2014
    Codexis to Report Third Quarter 2014 Financial Results on November 4 Oct 21 2014
    Codexis to Report Third Quarter 2014 Financial Results on November 4 Oct 21 2014
    CODEXIS INC Files SEC form 8-K, Change in Directors or Principal Officers Sep 22 2014
    Codexis Appoints Biotechnology Industry Veteran, Kathleen Glaub, to Board of Directors Sep 22 2014
    CODEXIS INC Files SEC form 10-Q, Quarterly Report Aug 08 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK